XJPX7840
Market cap278mUSD
Jan 15, Last price
1,259.00JPY
1D
0.56%
1Q
-0.79%
Jan 2017
35.52%
Name
France Bed Holdings Co Ltd
Chart & Performance
Profile
France Bed Holdings Co.,Ltd., through its subsidiaries, engages in the medical services, and home furnishing and health businesses in Japan. It manufactures, purchases, rents, retails, and wholesales medical beds, special needs equipment, beds, bedding, furniture, etc.; designs and develops mattresses; and manufactures wooden bed frames and other types of furniture. The company also manufactures, sells, and imports and exports medical and nursing care beds, home health equipment, special needs equipment, etc.; and maintains, inspects, and repairs nursing care and special needs equipment, as well as engages in the storage of products and control of inventory. In addition, it is involved in the sale of sundries; exhibition sales of furniture, and fashion and jewelry; setup of exhibition venues, etc.; and rental of special needs equipment. The company offers its products through a range of sales channels, including furniture stores, department stores, interior shops, and hotels. France Bed Holdings Co.,Ltd. was founded in 2004 and is based in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 59,151,000 0.98% | 58,578,000 7.68% | 54,398,000 3.75% | |||||||
Cost of revenue | 54,741,000 | 54,282,000 | 50,676,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 4,410,000 | 4,296,000 | 3,722,000 | |||||||
NOPBT Margin | 7.46% | 7.33% | 6.84% | |||||||
Operating Taxes | 1,574,000 | 1,664,000 | 1,326,000 | |||||||
Tax Rate | 35.69% | 38.73% | 35.63% | |||||||
NOPAT | 2,836,000 | 2,632,000 | 2,396,000 | |||||||
Net income | 3,134,000 15.99% | 2,702,000 5.67% | 2,557,000 11.42% | |||||||
Dividends | (1,330,000) | (1,230,000) | (1,152,000) | |||||||
Dividend yield | 2.86% | 3.22% | 3.61% | |||||||
Proceeds from repurchase of equity | 3,017,000 | 935,000 | 2,377,000 | |||||||
BB yield | -6.49% | -2.45% | -7.45% | |||||||
Debt | ||||||||||
Debt current | 4,900,000 | 6,128,000 | 9,435,000 | |||||||
Long-term debt | 18,027,000 | 14,094,000 | 12,616,000 | |||||||
Deferred revenue | 4,000 | 996,000 | 986,000 | |||||||
Other long-term liabilities | 1,775,000 | 612,000 | 615,000 | |||||||
Net debt | 5,401,000 | 1,097,000 | 4,031,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 7,829,000 | 8,928,000 | 6,011,000 | |||||||
CAPEX | (4,546,000) | (4,799,000) | (6,579,000) | |||||||
Cash from investing activities | (5,616,000) | (6,691,000) | (7,778,000) | |||||||
Cash from financing activities | 633,000 | (2,659,000) | 316,000 | |||||||
FCF | 1,836,000 | 4,203,000 | (1,698,000) | |||||||
Balance | ||||||||||
Cash | 16,702,000 | 12,855,000 | 11,278,000 | |||||||
Long term investments | 824,000 | 6,270,000 | 6,742,000 | |||||||
Excess cash | 14,568,450 | 16,196,100 | 15,300,100 | |||||||
Stockholders' equity | 42,381,000 | 79,830,000 | 77,775,000 | |||||||
Invested Capital | 43,740,550 | 36,375,900 | 38,632,900 | |||||||
ROIC | 7.08% | 7.02% | 6.70% | |||||||
ROCE | 7.56% | 8.17% | 6.90% | |||||||
EV | ||||||||||
Common stock shares outstanding | 36,082 | 36,121 | 36,871 | |||||||
Price | 1,288.00 21.74% | 1,058.00 22.31% | 865.00 -10.73% | |||||||
Market cap | 46,473,616 21.61% | 38,216,018 19.82% | 31,893,415 -14.15% | |||||||
EV | 51,874,616 | 76,080,018 | 71,601,415 | |||||||
EBITDA | 10,010,000 | 10,095,000 | 9,295,000 | |||||||
EV/EBITDA | 5.18 | 7.54 | 7.70 | |||||||
Interest | 83,000 | 91,000 | 74,000 | |||||||
Interest/NOPBT | 1.88% | 2.12% | 1.99% |